The following license files are associated with this item:
- QMRO Home
- William Harvey Research Institute
- Centre for Endocrinology
- Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways
Browse
Administrators only